a9449f
FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
REPORT OF FOREIGN ISSUER
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
Dated April
24, 2025
Commission
File Number: 001-04546
UNILEVER PLC
(Translation
of registrant's name into English)
UNILEVER HOUSE, BLACKFRIARS, LONDON, ENGLAND
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual
reports
under
cover Form 20-F or Form 40-F.
Form
20-F..X.. Form 40-F
Indicate
by check mark if the registrant is submitting the Form 6-K in
paper
as
permitted by Regulation S-T Rule 101(b)(1):_____
Indicate
by check mark if the registrant is submitting the Form 6-K in
paper
as
permitted by Regulation S-T Rule 101(b)(7):_____
Indicate
by check mark whether the registrant by furnishing the
information
contained
in this Form is also thereby furnishing the information to
the
Commission
pursuant to Rule 12g3-2(b) under the Securities Exchange Act of
1934.
Yes
No .X..
If
"Yes" is marked, indicate below the file number assigned to the
registrant
in
connection with Rule 12g3-2(b): 82- _______
Exhibit
99 attached hereto is incorporated herein by
reference.
Signatures
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
UNILEVER
PLC
|
|
|
|
/S/ M VARSELLONA
|
BY M VARSELLONA
|
CHIEF LEGAL OFFICER AND GROUP SECRETARY
|
Date:
24 April, 2025
EXHIBIT
INDEX
------------------------
EXHIBIT
NUMBER
|
EXHIBIT
DESCRIPTION
|
99
|
Notice
to London Stock Exchange dated 24 April 2025
|
|
Q1 2025
Trading Statement
|
Exhibit
99
Unilever
Trading Statement - First Quarter 2025
|
|
Resilient
performance, full year outlook reconfirmed
|
|
First
Quarter 2025
|
(unaudited)
|
USG
|
Turnover
|
vs 2024
|
Unilever
|
3.0%
|
€14.8bn
|
(0.9)%
|
Beauty
& Wellbeing
|
4.1%
|
€3.3bn
|
2.9%
|
Personal
Care
|
5.1%
|
€3.3bn
|
(4.4)%
|
Home
Care
|
0.9%
|
€3.0bn
|
(4.2)%
|
Foods
|
1.6%
|
€3.4bn
|
0.1%
|
Ice
Cream
|
4.0%
|
€1.8bn
|
2.8%
|
First Quarter highlights
● Underlying
sales growth (USG) of 3.0%, with volume growth of 1.3% and price of
1.7%
● Turnover
of €14.8 billion, down (0.9)% including (2.7)% from net
disposals
● 2025
full year outlook reconfirmed with
3-5% USG and a modest improvement in underlying operating
margin
● Productivity
programme ahead of plan, delivering an aggregate c.€550
million savings by end 2025
● Ice
Cream separation on track, Capital Markets Day on
9th September
ahead of demerger in Q4
● Ongoing
€1.5 billion share buyback to
be completed in first half of 2025
Chief Executive Officer statement
"We have started the year with a resilient performance. First
quarter underlying sales growth of 3% reflects the strength of our
increasingly premium and innovation-led portfolio in developed
markets. We have interventions in place in some emerging markets to
step up growth in the remainder of the year.
Heightened global macroeconomic uncertainty is a fact; however the
quality of our innovation programme, the strong investment behind
our brands and our improving competitiveness give us confidence we
will deliver on our full year plans.
Creating desirability at scale for our brands and brilliant
in-market execution are the pillars of our plan to turn Unilever
into a consistently higher performing business. We are moving at
pace, confident in making progress in 2025 and
beyond."
Fernando Fernandez
We reconfirm our full year 2025 outlook.
We expect underlying sales growth to be within our range of 3% to
5%. This is underpinned by our strong innovation pipeline, good
momentum in developed markets, and expected improvements in
Indonesia and China in the second half of the year resulting
from the decisive actions we have taken in both
markets.
We anticipate a modest improvement in underlying operating margin
for the full year, versus 18.4% in 2024. Margins in the first and
second half will be more balanced than in 2024. The direct impact
of tariffs on our profitability is expected to be limited and
manageable.
All this being said, we are conscious that the macroeconomic
environment, currency stability and consumer sentiment remain
uncertain and we will be agile in adjusting our plans as
necessary.
First
Quarter Review: Unilever Group
|
(unaudited)
|
Turnover
|
USG
|
UVG
|
UPG
|
Acquisitions
|
Disposals
|
Currency
|
Turnover change
|
First Quarter
|
€14.8bn
|
3.0%
|
1.3%
|
1.7%
|
0.1%
|
(2.8)%
|
(1.1)%
|
(0.9)%
|
Performance
Underlying sales growth in the first quarter was 3.0%, driven by
both volume and price. As expected, market conditions were more
challenging than in the prior year. Our Power Brands grew at
3.0% with
strong performances in our largest brand Dove,
which grew over 8%, as well as Vaseline, Liquid
I.V., and Magnum.
This was partially offset by Home Care Power Brands that were
impacted by market conditions, particularly in Brazil,
and Knorr which
cycled a strong double-digit comparator in our Unilever
Food Solutions business.
Beauty & Wellbeing grew underlying sales by 4.1%, with volume
growth of 2.5% and price of 1.5%, driven by continued strong
double-digit growth from our Wellbeing brands. Personal Care grew
5.1%, with volume up 2.7%, driven by the performance of Skin
Cleansing and Deodorants in North America. Home Care underlying
sales increased 0.9% as the continued strong growth in Europe,
fuelled by the rollout of premium innovations, was largely offset
by challenging market conditions in Latin America. Underlying sales
growth of 1.6% in Foods was price-led amidst slow markets. Ice
Cream grew 4.0%, benefiting from the continued innovation quality
and operational improvements.
Developed markets (42% of group turnover) grew underlying sales
4.5%, with volumes of 3.3% and 1.2% from price. It was the third
consecutive quarter of USG above 4% in developed markets. Volume
growth was broad-based, with strong performances in North America
driven by Beauty & Wellbeing and Personal Care, and in Europe
driven by Home Care.
Emerging markets (58% of group turnover) grew underlying sales
2.0%, with volumes of (0.1)% and 2.1% from price. Growth in Latin
America slowed to 1.5%, with volume declining (3.0)% as high real
interest rates prompted retailers to reduce trade stocks. India
grew 3% driven by volume growth in Home Care and Beauty &
Wellbeing. Market growth in China remained subdued and underlying
sales declined high-single digit. Indonesia declined (6.6)% as we
continued our operational turnaround of the business. We expect
both markets to contribute to growth from the second half of the
year.
Turnover was €14.8 billion, a decline of (0.9)% compared to
the prior year, as underlying sales growth was more than offset by
(2.7)% from disposals net of acquisitions and a (1.1)% negative
currency impact.
Ice Cream separation
We are on track to complete the separation of Ice Cream in the
fourth quarter of 2025. The new business will be called The Magnum
Ice Cream Company and is expected to operate on a standalone basis
from 1st July.
Ice Cream will be reported as a discontinued operation from the
fourth quarter.
The Magnum Ice Cream Company will be separated by way of demerger,
through listing of the business in Amsterdam, London and New York,
the same three exchanges on which Unilever PLC shares are currently
traded. The business will be incorporated in the Netherlands and
will continue to be headquartered in Amsterdam. Ahead of its
demerger, The Magnum Ice Cream Company will hold a Capital Markets
Day on 9th September.
Productivity programme
The divisionalisation of our sales force has been put in place
during Q1 in all of our top 24 markets. This is an important step
to ensure maximum category focus and accountability.
Our productivity programme, launched in 2024 to simplify the
business and further evolve our category-focused business model,
remains ahead of plan in its delivery of €800 million of
savings and a reduction of 7,500 mainly office-based
roles.
By the end of the first quarter, there was a reduction of around
6,000 FTEs and we expect to realise around €550 million of
the programme's savings by the end of 2025. We continue to expect
restructuring costs of around 1.4% of Group turnover in 2025, while
reaffirming our guidance that we expect average restructuring costs
to be around 1.2% of Group turnover over the three-year period from
2024 to 2026.
Capital allocation
In January 2025, Hindustan Unilever Limited announced it has signed
an agreement to acquire the premium actives-led beauty brand
Minimalist, as it continues to evolve its Beauty & Wellbeing
portfolio towards higher growth and demand spaces in
India.
In March 2025, Unilever announced it has agreed the sale of The
Vegetarian Butcher, a non-strategic asset, given its limited
scalability.
In April 2025, Unilever acquired the personal care brand Wild,
further enhancing our Personal Care portfolio in premium and high
growth spaces.
The quarterly interim dividend for the first quarter is
€0.4528, in line with the Q4 2024 dividend and up 6.1% vs Q1
2024.
The €1.5 billion share buyback programme, announced in
February 2025, is well underway and will be completed in the first
half.
Following the release of this trading statement on 24
April 2025 at 7:00 AM (UK time), there will be a webcast
at 8:00 AM available on the website www.unilever.com/investor-relations/results-and-presentations/latest-results.
A replay of the webcast and the slides of the presentation will be
made available after the live meeting.
Date
|
Events
|
31 July 2025
|
Half year and second quarter results
|
9 September 2025
|
The Magnum Ice Cream Company Capital Markets Day
|
23 October 2025
|
Third quarter trading statement
|
First
Quarter Review: Business Groups
|
|
First
Quarter 2025
|
(unaudited)
|
Turnover
|
USG
|
UVG
|
UPG
|
Unilever
|
€14.8bn
|
3.0%
|
1.3%
|
1.7%
|
Beauty
& Wellbeing
|
€3.3bn
|
4.1%
|
2.5%
|
1.5%
|
Personal
Care
|
€3.3bn
|
5.1%
|
2.7%
|
2.4%
|
Home
Care
|
€3.0bn
|
0.9%
|
1.0%
|
-%
|
Foods
|
€3.4bn
|
1.6%
|
(1.1)%
|
2.7%
|
Ice
Cream
|
€1.8bn
|
4.0%
|
1.8%
|
2.2%
|
Beauty & Wellbeing (22%
of Q1 Group turnover)
In Beauty & Wellbeing, we focus on three key priorities:
premiumising our core Hair and Skin Care portfolios by emphasising
brand superiority; fuelling the growth of our Prestige Beauty and
Wellbeing portfolios with selective international expansion; and,
continuing to strengthen our competitiveness through innovation and
a social-first approach to consumer engagement.
(unaudited)
|
Turnover
|
USG
|
UVG
|
UPG
|
Acquisitions
|
Disposals
|
Currency
|
Turnover change
|
First Quarter
|
€3.3bn
|
4.1%
|
2.5%
|
1.5%
|
0.3%
|
(1.5)%
|
0.1%
|
2.9%
|
Beauty & Wellbeing underlying sales grew 4.1% with 2.5% from
volume and 1.5% from price. Growth was driven by a strong Wellbeing
performance, that was partially offset by a slower beauty
market.
Hair Care was flat with low-single digit price offset by a
low-single digit volume decline. Dove grew
mid-single digit, supported by its relaunch with cutting edge fibre
repair technology, new packaging and design. Our largest hair care
brand, Sunsilk,
was flat as it lapped a strong double-digit growth comparator and
faced some destocking in Brazil. Nexxus grew
strong double-digit, which was supported by the launch of its
HY-Volume range. Clear declined
as market growth remained challenged in its primary market,
China.
Core Skin Care grew low-single digit driven by low-single digit
volume. Both Vaseline and Dove continued
to grow double-digit, supported by the rollouts
of Vaseline's
Pro Derma Ceramide range and Dove's
body serums across the Americas. Pond's launched
its new Ultra Light Biome range across Asia which uses its
cera-hyamino technology to hydrate and strengthen the skin
barrier.
Wellbeing delivered strong double-digit growth, led
by Liquid
I.V. and Nutrafol. Liquid
I.V. continued
to gain share in fast-growing digital channels, supported by
successful multi-year innovations such as its sugar-free
variant. Olly grew
well with double-digit volume driven by a strong performance in
digital channels.
Prestige Beauty declined low-single digit reflecting the slowdown
in the beauty market. Hourglass and Tatcha continued
to grow double-digit while Paula's
Choice and Dermalogica declined. K18,
a premium biotech hair care brand, grew strong double-digit and it
has been included in underlying sales growth from February
2025.
Personal Care (22%
of Q1 Group turnover)
In Personal Care, we focus on winning with science-led brands that
deliver unmissable superiority to our consumers across Deodorants,
Skin Cleansing, and Oral Care. Our priorities include developing
superior technology and multi-year innovation platforms, leveraging
partnerships with our customers, and expanding into premium areas
and digital channels.
(unaudited)
|
Turnover
|
USG
|
UVG
|
UPG
|
Acquisitions
|
Disposals
|
Currency
|
Turnover change
|
First Quarter
|
€3.3bn
|
5.1%
|
2.7%
|
2.4%
|
-%
|
(7.1)%
|
(2.1)%
|
(4.4)%
|
Personal Care underlying sales grew 5.1% with 2.7% from volume and
2.4% from price.
Dove, which represents c.40% of Personal Care's turnover, grew
high-single digit with high-single digit volume and positive price.
This growth was driven by the continued success and rollout
of Dove's
serum shower collection and whole-body
deodorants. Dove's performance
was also supported by its Super Bowl advertising
campaign.
Deodorants grew mid-single digit with balanced volume and price.
This was led by Dove,
which grew double-digit volume, with strong results in North
America. Rexona was
flat while Axe declined
low-single digit as both brands faced challenges due to their large
footprints in Latin America, where there was economic pressure
during the quarter.
Skin Cleansing grew low-single digit, driven by positive volume and
price. Dove led
this growth with strong performances in North America and Europe.
The brand's success was supported by Dove
Men+Care, which introduced a new range of premium naturals and
relaunched its core range with updated packaging and
design. Lux grew
low-single digit while Lifebuoy declined,
due to poor performance in Indonesia, China, and India. In
India, Lifebuoy was
relaunched with an elevated proposition for skin
protection.
Oral Care grew mid-single digit led by price. Close-up grew
high-single digit, which benefited from the launch of its whitening
range across markets in Asia, while Pepsodent grew
mid-single digit.
Home Care (21%
of Q1 Group turnover)
In Home Care, we focus on delivering for consumers who want
superior products that are sustainable and great value. We drive
growth through unmissable superiority in our biggest brands, in our
key markets and across channels. We have a resilient business that
spans price points and grows the market by premiumising and trading
consumers up to additional benefits.
(unaudited)
|
Turnover
|
USG
|
UVG
|
UPG
|
Acquisitions
|
Disposals
|
Currency
|
Turnover change
|
First Quarter
|
€3.0bn
|
0.9%
|
1.0%
|
-%
|
-%
|
(2.5)%
|
(2.6)%
|
(4.2)%
|
Home Care underlying sales grew 0.9% with 1.0% from volume and flat
price.
Fabric Cleaning declined low-single digit with a low-single digit
decline in volume. Growth was impacted by challenging market
conditions in Brazil, where very high real interest rates led to
some retailer destocking. In India, volumes grew mid-single digit
while deflationary conditions resulted in increased promotional
intensity and price reductions in the market. Europe grew
high-single digit, driven by the success of multi-year innovation
platforms, including the continued expansion of Persil Wonder
Wash which introduced new variants, Colour and Sensitive, and
entered new markets.
Home & Hygiene grew mid-single digit with balanced volume and
price. Domestos grew
mid-single digit while CIF grew
high-single digit. At the end of the quarter, CIF launched
its new Infinite Clean range powered by probiotics that break down
dirt and grime for up to three days.
Fabric Enhancers grew high-single digit driven by high-single digit
volume. Comfort continued
to grow well with strong volume as it expanded the successful
Botanicals and Elixir ranges launched last
year.
Foods (23%
of Q1 Group turnover)
In Foods, our strategy is to deliver consistent, competitive growth
by offering unmissably superior products through our biggest
brands. We do this by reaching more consumers and focusing on top
dishes and high consumption seasons to satisfy consumers'
preferences on taste, health and sustainability; while delivering
productivity and resilience in our supply chain.
(unaudited)
|
Turnover
|
USG
|
UVG
|
UPG
|
Acquisitions
|
Disposals
|
Currency
|
Turnover change
|
First Quarter
|
€3.4bn
|
1.6%
|
(1.1)%
|
2.7%
|
-%
|
(0.5)%
|
(0.9)%
|
0.1%
|
Foods underlying sales grew 1.6% with (1.1)% from volume and 2.7%
from price.
Cooking Aids grew low-single digit driven by
price. Knorr grew
low-single digit as it continued to enhance its leadership in
Bouillon with new flavours and the relaunch of its core Chicken
& Beef powder.
Condiments grew low-single digit with positive volume and
price. Hellmann's grew
mid-single digit with positive volume and price. This growth was
led by the Flavoured mayo range, now available in 30 markets. In
the first quarter, several new variants were launched, including
Ranch in the US and Flamin' Hot in Mexico. In North
America, Hellmann's launched
a better-for-you avocado oil variant and a new range of Mayo Dips
designed to complement barbeque favourites.
Unilever Food Solutions was
flat. In China, Unilever
Food Solutions' largest
market, sales declined as it lapped strong double-digit growth from
the prior year which benefited from the later Chinese New Year. In
North America, growth was mid-single digit, driven by continued
customer expansion through Hellmann's food
solution ranges.
India Foods declined low-single digit, as growth
in Beverages was fully offset by a decline
in Horlicks.
Ice Cream (12%
of Q1 Group turnover)
In Ice Cream, we are focused on continuing to strengthen the
business in preparation for Ice Cream's separation by the end of
2025. We are doing this by developing an exciting product pipeline,
designing more efficient go-to-market strategies, optimising our
supply chain, and building a dedicated sales team globally. The
separation will create a world-leading business, operating in a
highly attractive category with five of the top 10 selling global
ice cream brands.
(unaudited)
|
Turnover
|
USG
|
UVG
|
UPG
|
Acquisitions
|
Disposals
|
Currency
|
Turnover change
|
First Quarter
|
€1.8bn
|
4.0%
|
1.8%
|
2.2%
|
-%
|
(1.6)%
|
0.4%
|
2.8%
|
Ice Cream underlying sales grew 4.0% with 1.8% from volume and 2.2%
from price. The positive performance reflects strong innovations
and the continued improvement in our operations as we approach the
summer season.
In-home Ice Cream (approximately 60% of total Ice Cream sales)
delivered mid-single digit growth with positive volume and price.
Out-of-home Ice Cream (around 40% of total Ice Cream sales) grew
low-single digit driven by price.
Magnum grew
mid-single digit supported by the introduction of its Utopia range,
featuring new flavours, Double Cherry and Double
Hazelnut. Yasso grew
double-digit and expanded its Poppables and Bars ranges to new
flavours.
This quarter saw the rollout and introduction of several premium
products, including further expansion of Magnum Bon
Bons into additional European markets, the launch
of Cornetto's
Disk cones in Europe and Australia, and Ben
& Jerry's launch
of a larger, shareable size and new Sundae
flavours.
First
Quarter Review: Geographical Areas
|
|
First
Quarter 2025
|
(unaudited)
|
Turnover
|
USG
|
UVG
|
UPG
|
Unilever
|
€14.8bn
|
3.0%
|
1.3%
|
1.7%
|
Asia
Pacific Africa
|
€6.5bn
|
2.0%
|
0.6%
|
1.3%
|
The
Americas
|
€5.4bn
|
4.2%
|
1.1%
|
3.1%
|
Europe
|
€2.9bn
|
3.2%
|
3.0%
|
0.2%
|
|
First
Quarter 2025
|
(unaudited)
|
Turnover
|
USG
|
UVG
|
UPG
|
Emerging
markets
|
€8.6bn
|
2.0%
|
(0.1)%
|
2.1%
|
Developed
markets
|
€6.2bn
|
4.5%
|
3.3%
|
1.2%
|
North
America
|
€3.3bn
|
6.2%
|
4.0%
|
2.1%
|
Latin
America
|
€2.1bn
|
1.5%
|
(3.0)%
|
4.6%
|
Asia Pacific Africa (44%
of Q1 Group turnover)
Underlying sales growth was 2.0%, with 0.6% from volume and 1.3%
from price.
India grew 3% with 2% underlying volume growth. Beauty &
Wellbeing and Personal Care delivered low-single digit growth, led
by continued strong growth in Hair Care and price-led growth in
Skin Cleansing. Low-single digit growth in Home Care was driven by
strong volume growth and partially offset by negative price. Foods
declined low-single digit due, driven by Horlicks.
China declined high-single digit on the back of broad-based market
weakness. In this environment, we continued to focus on
strengthening our business. We are accelerating portfolio
premiumisation through innovations in our Power Brands and serving
emerging channels better, through social-first demand creation and
direct-to-consumer models. At the same time, we have been
transforming our go-to-market approach with a tailored customer
development organisation and digital selling tools for our
salesforce and distributors, to serve fast-growing e-commerce
channels and smaller format stores in lower tier
cities.
Growth in South East Asia was muted as high-single digit growth in
the Philippines was offset by a (6.6)% decline in Indonesia. We are
making progress with the operational turnaround in Indonesia,
correcting misaligned pricing across channels, resetting stock
levels in retail, and addressing long-standing portfolio issues.
This is not a short-term fix, but we continue to expect to see
Indonesia and China contribute to growth from the second half of
2025.
Turkey, which remains hyperinflationary, continued to deliver
double-digit growth with positive price and volume growth. Africa
had a more muted start to the year, affected by a decline in its
biggest market South Africa.
The Americas (36%
of Q1 Group turnover)
Underlying sales growth was 4.2%, with 1.1% from volume and 3.1%
from price.
North America grew 6.2%, with volume up 4.0%, benefiting from the
multi-year transformation of our North American portfolio which
showed resilience in spite of declining consumer sentiment. Growth
was led by the continued success of our Wellbeing brands and by
premiumisation of our brands in Personal Care. Performance in
Deodorants was supported by the roll out of our whole body
innovation across brands, expanding the deodorant segment beyond
underarms. All five Business Groups grew in the first
quarter.
Latin America grew 1.5%, with 4.6% price and negative volumes of
(3.0)%. Economic conditions and sentiment worsened across the
region, with very high real interest rates prompting retailers to
reduce stocks, especially in Brazil. As a result, our biggest
market Brazil declined slightly, while volume growth in Mexico and
Argentina turned negative. Home Care declined in the quarter.
Growth in the other Business Groups was positive and price-led,
with Beauty & Wellbeing and Personal Care lapping strong prior
year comparators of double-digit volume growth.
Europe (20%
of Q1 Group turnover)
Underlying sales growth was 3.2%, with volume growth of 3.0% and
price of 0.2%.
Home Care continued to deliver high-single digit growth supported
by its strong innovation programme across Fabric Cleaning and
Fabric Enhancers. Personal Care and Ice Cream grew mid-single
digits, led by volume, with Ice Cream seeing the benefit of
operational improvements and distribution gains ahead of the summer
season. Foods declined slightly amidst weaker consumer demand. By
country, Italy and Poland started strongly into the year, while
growth in the United Kingdom was virtually flat against a strong
prior year comparator.
Segment
Information - Business Groups
|
(unaudited)
|
|
|
|
|
|
|
First Quarter
|
Beauty & Wellbeing
|
Personal Care
|
Home Care
|
Foods
|
Ice Cream
|
Total
|
Turnover (€ million)
|
|
|
|
|
|
|
2024
|
3,187
|
3,409
|
3,191
|
3,388
|
1,788
|
14,963
|
2025
|
3,280
|
3,260
|
3,057
|
3,393
|
1,838
|
14,828
|
Change (%)
|
2.9
|
(4.4)
|
(4.2)
|
0.1
|
2.8
|
(0.9)
|
Impact of:
|
|
|
|
|
|
|
Acquisitions
(%)
|
0.3
|
-
|
-
|
-
|
-
|
0.1
|
Disposals
(%)
|
(1.5)
|
(7.1)
|
(2.5)
|
(0.5)
|
(1.6)
|
(2.8)
|
Currency-related
items (%), of which:
|
0.1
|
(2.1)
|
(2.6)
|
(0.9)
|
0.4
|
(1.1)
|
Exchange rates changes (%)
|
(0.6)
|
(2.5)
|
(3.1)
|
(1.5)
|
(1.0)
|
(1.8)
|
Extreme price growth in hyperinflationary markets*
|
0.7
|
0.5
|
0.5
|
0.6
|
1.5
|
0.7
|
Underlying sales growth (%)
|
4.1
|
5.1
|
0.9
|
1.6
|
4.0
|
3.0
|
Price* (%)
|
1.5
|
2.4
|
-
|
2.7
|
2.2
|
1.7
|
Volume (%)
|
2.5
|
2.7
|
1.0
|
(1.1)
|
1.8
|
1.3
|
* Underlying price growth in excess of 26% per year in
hyperinflationary economies has been excluded when calculating the
price growth in the tables above, and an equal and opposite amount
is shown as extreme price growth in hyperinflationary
markets.
Turnover growth is made up of distinct individual growth components
namely underlying sales, currency impact, acquisitions and
disposals. Turnover growth is arrived at by multiplying these
individual components on a compounded basis as there is a currency
impact on each of the other components. Accordingly, turnover
growth is more than just the sum of the individual
components.
Segment
Information - Geographical Areas
|
(unaudited)
|
|
|
|
|
First Quarter
|
Asia Pacific Africa
|
The Americas
|
Europe
|
Total
|
Turnover (€ million)
|
|
|
|
|
2024
|
6,612
|
5,502
|
2,849
|
14,963
|
2025
|
6,486
|
5,448
|
2,894
|
14,828
|
Change (%)
|
(1.9)
|
(1.0)
|
1.6
|
(0.9)
|
Impact of:
|
|
|
|
|
Acquisitions
(%)
|
-
|
0.2
|
-
|
0.1
|
Disposals
(%)
|
(3.5)
|
(2.3)
|
(2.1)
|
(2.8)
|
Currency-related
items (%), of which:
|
(0.3)
|
(3.0)
|
0.6
|
(1.1)
|
Exchange rates changes (%)
|
(1.0)
|
(4.0)
|
0.6
|
(1.8)
|
Extreme price growth in hyperinflationary markets*
|
0.6
|
1.1
|
-
|
0.7
|
Underlying sales growth (%)
|
2.0
|
4.2
|
3.2
|
3.0
|
Price* (%)
|
1.3
|
3.1
|
0.2
|
1.7
|
Volume (%)
|
0.6
|
1.1
|
3.0
|
1.3
|
* Underlying price growth in excess of 26% per year in
hyperinflationary economies has been excluded when calculating the
price growth in the tables above, and an equal and opposite amount
is shown as extreme price growth in hyperinflationary
markets.
The Board has declared a quarterly interim dividend for Q1 2025 of
€0.4528 per Unilever PLC ordinary share or £0.3887 per
Unilever PLC ordinary share at the applicable exchange rate issued
by WM/Reuters on 22 April 2025.
The following amounts will be paid in respect of this quarterly
interim dividend on the relevant payment date:
Per Unilever PLC ordinary share (traded on the London Stock
Exchange):
|
£0.3887
|
Per Unilever PLC ordinary share (traded on Euronext in
Amsterdam):
|
€0.4528
|
Per Unilever PLC American Depositary Receipt:
|
US$0.5201
|
The pound sterling and US dollar amounts above have been determined
using the applicable exchange rates issued by WM/Reuters on 22
April 2025.
US dollar cheques for the quarterly interim dividend will be mailed
on 13 June 2025 to holders of record at the close of business
on 16 May 2025.
The quarterly dividend calendar for the remainder of 2025 will be
as follows:
|
Announcement
Date
|
Ex-dividend Date for
Ordinary Shares
|
Ex-dividend Date for
ADRs
|
Record Date
|
Last Date for DRIP
Election
|
Payment Date
|
Q1 2025 Dividend
|
24 April 2025
|
15 May 2025
|
16 May 2025
|
16 May 2025
|
22 May 2025
|
13 June 2025
|
Q2 2025 Dividend
|
31 July 2025
|
14 August 2025
|
15 August 2025
|
15 August 2025
|
21 August 2025
|
12 September 2025
|
Q3 2025 Dividend
|
23 October 2025
|
06 November 2025
|
07 November 2025
|
07 November 2025
|
14 November 2025
|
05 December 2025
|
In our financial reporting we use certain measures that are not
defined by generally accepted accounting principles (GAAP) such as
IFRS. We believe this information, along with comparable GAAP
measurements, is useful to investors because it provides a basis
for measuring our operating performance, and our ability to retire
debt and invest in new business opportunities. Our management uses
these financial measures, along with the most directly comparable
GAAP financial measures, in evaluating our operating performance
and value creation. Non-GAAP financial measures should not be
considered in isolation from, or as a substitute for, financial
information presented in compliance with GAAP. Wherever appropriate
and practical, we provide reconciliations to relevant GAAP
measures. The non-GAAP measures used in this announcement are
underlying sales growth, underlying volume growth and underlying
price growth (see below).
Underlying sales growth (USG)
Underlying sales growth (USG) refers to the increase in turnover
for the period, excluding any change in turnover resulting from
acquisitions, disposals, changes in currency and price growth in
excess of 26% in hyperinflationary economies. Inflation of 26% per
year compounded over three years is one of the key indicators
within IAS 29 to assess whether an economy is deemed to be
hyperinflationary. We believe this measure provides valuable
additional information on the underlying sales performance of the
business and is a key measure used internally. The impact of
acquisitions and disposals is excluded from USG for a period of 12
calendar months from the applicable closing date. Turnover from
acquired brands that are launched in countries where they were not
previously sold is included in USG as such turnover is more
attributable to our existing sales and distribution network than
the acquisition itself. The reconciliation of changes in the GAAP
measure turnover to USG is provided on page 8.
Underlying price growth (UPG)
Underlying price growth (UPG) is part of USG and means, for the
applicable period, the increase in turnover attributable to changes
in prices during the period. UPG therefore excludes the impact to
USG due to (i) the volume of products sold; and (ii) the
composition of products sold during the period. In determining
changes in price we exclude the impact of price growth in excess of
26% per year in hyperinflationary economies as explained in USG
above. The measures and the related turnover GAAP measure are set
out on page 8.
Underlying volume growth (UVG)
Underlying volume growth (UVG) is part of USG and means, for the
applicable period, the increase in turnover in such period
calculated as the sum of (i) the increase in turnover attributable
to the volume of products sold; and (ii) the increase in turnover
attributable to the composition of products sold during such
period. UVG therefore excludes any impact on USG due to changes in
prices. The measures and the related turnover GAAP measure are set
out on page 8.
This announcement may contain forward-looking statements within the
meaning of the securities laws of certain jurisdictions, including
'forward-looking statements' within the meaning of the United
States Private Securities Litigation Reform Act of 1995. All
statements other than statements of historical fact are, or may be
deemed to be, forward-looking statements. Words and terminology
such as 'will', 'aim', 'expects', 'anticipates', 'intends',
'looks', 'believes', 'vision', 'ambition', 'target', 'goal',
'plan', 'potential', 'work towards', 'may', 'milestone',
'objectives', 'outlook', 'probably', 'project', 'risk', 'continue',
'should', 'would be', 'seeks', or the negative of these terms and
other similar expressions of future performance, results, actions
or events, and their negatives, are intended to identify such
forward-looking statements. Forward-looking statements also
include, but are not limited to, statements and information
regarding Unilever's emissions reduction and other
sustainability-related targets and other climate and sustainability
matters (including actions, potential impacts and risks and
opportunities associated therewith). Forward-looking statements can
be made in writing but also may be made verbally by directors,
officers and employees of the Unilever Group (the "Group")
(including during management presentations) in connection with this
announcement. These forward-looking statements are based upon
current expectations and assumptions regarding anticipated
developments and other factors affecting the Group. They are not
historical facts, nor are they guarantees of future performance or
outcomes. All forward-looking statements contained in this
announcement are expressly qualified in their entirety by the
cautionary statements contained in this section. Readers should not
place undue reliance on forward-looking statements.
Because these forward-looking statements involve known and unknown
risks and uncertainties, a number of which may be beyond the
Group's control, there are important factors that could cause
actual results to differ materially from those expressed or implied
by these forward-looking statements. Among other risks and
uncertainties, the material or principal factors which could cause
actual results to differ materially from the forward-looking
statements expressed in this announcement are: Unilever's global
brands not meeting consumer preferences; Unilever's ability to
innovate and remain competitive; Unilever's investment choices in
its portfolio management; the effect of climate change on
Unilever's business; Unilever's ability to find sustainable
solutions to its plastic packaging; significant changes or
deterioration in customer relationships; the recruitment and
retention of talented employees; disruptions in Unilever's supply
chain and distribution; increases or volatility in the cost of raw
materials and commodities; the production of safe and high-quality
products; secure and reliable IT infrastructure; execution of
acquisitions, divestitures and business transformation projects,
including the proposed separation of our Ice Cream business;
economic, social and political risks and natural disasters;
financial risks; failure to meet high and ethical standards; and
managing regulatory, tax and legal matters and practices with
regard to the interpretation and application thereof and emerging
and developing ESG reporting standards including differences in
implementation of climate and sustainability policies in the
regions where the Group operates.
The forward-looking statements are based on our beliefs,
assumptions and expectations of our future performance, taking into
account all information currently available to us. Forward-looking
statements are not predictions of future events. These beliefs,
assumptions and expectations can change as a result of many
possible events or factors, not all of which are known to us. If a
change occurs, our business, financial condition, liquidity and
results of operations may vary materially from those expressed in
our forward-looking statements.
The forward-looking statements speak only as of the date of this
announcement. Except as required by any applicable law or
regulation, the Group expressly disclaims any intention, obligation
or undertaking to release publicly any updates or revisions to any
forward-looking statements contained herein to reflect any change
in the Group's expectations with regard thereto or any change in
events, conditions or circumstances on which any such statement is
based. New risks and uncertainties arise over time, and it is not
possible for us to predict those events or how they may affect us.
In addition, we cannot assess the impact of each factor on our
business or the extent to which any factor, or combination of
factors, may cause actual events, to differ materially from those
contained in any forward-looking statements. Further details of
potential risks and uncertainties affecting the Group are described
in the Group's filings with the London Stock Exchange, Euronext
Amsterdam and the US Securities and Exchange Commission, including
in the Annual Report on Form 20-F 2024 and the Unilever Annual
Report and Accounts 2024.
Media:
Media Relations Team
|
Investors: Investor
Relations Team
|
UK
|
+44 78 2527 3767
|
|
|
or
|
+44 77 7999 9683
|
|
|
NL
|
+31 63 029 6394
|
|
|
or
|
+31 61 500 8293
|
|
|
After the conference call on 24 April 2025 at 8:00 AM (UK time),
the webcast of the presentation will be available
at www.unilever.com/investor-relations/results-and-presentations/latest-results.
This Results Presentation has been submitted to the FCA National
Storage Mechanism and is available for inspection
at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.